“Shook, Hardy & Bacon’s Hildy Sastre and Jon Strongman successfully defended Sanofi-Aventis in the first bellwether trial over the chemotherapy drug Taxotere," ALM said. “After a two-week trial, federal jury in New Orleans deliberated for less than two hours before siding with the defense across the board in the closely-watched test case.”
The jury verdict was the first trial result in an MDL of more than 11,000 cases.
The case is Earnest v. Sanofi Aventis U.S. LLC, No. 16-17144 (E.D. La.)